Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07102147 · ClinicalTrials.gov registry record · NA

Telehealth Collaborative Care Model (CoCM) in Lung Cancer

A NA study of Anxiety and Lung Cancer (Diagnosis), sponsored by Abramson Cancer Center at Penn Medicine.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT07102147 is a NA study of Anxiety and Lung Cancer (Diagnosis) that is actively recruiting participants, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 30 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07102147, a NA study of Anxiety and Lung Cancer (Diagnosis), is actively recruiting participants, sponsored by Abramson Cancer Center at Penn Medicine.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The goal of this trial is to compare the impact of two outreach strategies (high touch vs. standard outreach) on a collaborative care program delivered via telehealth to patients with lung cancer.

Interventions

  • BEHAVIORAL High Touch Outreach

Study Locations (1)

Pennsylvania

  • Abramson Cancer Center at the University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-08-18
Est. Completion 2027-02
Phase NA

What the Registry Record Tells You About NCT07102147

The ClinicalTrials.gov registry entry for NCT07102147 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (93% lower). The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which High Touch Outreach is the first listed.

NCT07102147 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT07102147 about?

NCT07102147 is a clinical study titled "Telehealth Collaborative Care Model (CoCM) in Lung Cancer". The goal of this trial is to compare the impact of two outreach strategies (high touch vs. standard outreach) on a collaborative care program delivered via telehealth to patients with lung cancer.

What is the current status of trial NCT07102147?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-08-18. Estimated completion is 2027-02.

What conditions does trial NCT07102147 study?

This clinical trial studies the following conditions: Anxiety, Lung Cancer (Diagnosis), Depression in Adults.

What interventions are being tested in trial NCT07102147?

The interventions under investigation include: High Touch Outreach (BEHAVIORAL).

Who is sponsoring clinical trial NCT07102147?

This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07102147 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.